BioSpace News Archive

Business

I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022

I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced its financial results for the 12 months ended December 31, 2022, and provided key business updates.

March 31, 2023
·
39 min read
BioMidwest

Centene Recognized by Fortune as One of “America’s Most Innovative Companies”

Centene Corporation announced it has been named one of America’s Most Innovative Companies by Fortune magazine.

March 31, 2023
·
2 min read
Business

LABCORP TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS ON APRIL 25, 2023

Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the first quarter of 2023 before the market opens on Tuesday, April 25, 2023.

March 31, 2023
·
1 min read
Business

Mednow Achieves Record Q2 2023 Financial Results with Quarterly Revenue of $11.3 Million; 17% Q/Q Revenue Growth and 466% Y/Y Revenue Growth; Adjusted EBITDA Improved 32% Y/Y; and Cash Flow from Operations Improved by 7% Q/Q

Mednow Inc., Canada’s on-demand virtual pharmacy, is pleased to announce it has released its financial results for the period ending January 31, 2023.

March 31, 2023
·
15 min read
Deals

Qiming Venture Partners Welcomes Apollomics’ Successful IPO on Nasdaq

On March 30, 2023, Apollomics Inc., an innovative biopharmaceutical company and portfolio company of Qiming Venture Partners, listed on Nasdaq through a SPAC merger with Maxpro Capital Acquisition Corp.

March 31, 2023
·
3 min read
Biotech Beach

Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up

Telesis Bio Inc. announced continued expansion of the BioXp® Select Kit product line, releasing two novel kits to enable DNA amplification and scale-up.

March 31, 2023
·
3 min read
Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China

Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients in China, today announced the development plans of a first-in-class novel peptide drug candidate against GPC3.

March 31, 2023
·
3 min read
Calliditas to participate in upcoming April 2023 investor conferences

Calliditas Therapeutics AB announced its management’s participation in the following investor conferences.

March 31, 2023
·
2 min read
Bio NC

CMP Pharma’s Potassium Phosphates Injection Receives FDA Shelf Life Extension for Specific Lots

CMP Pharma announced today that in order to mitigate drug shortage concerns, the FDA’s CDER Office of Compliance has granted a shelf life extension for CMP Development LLC Potassium Phosphates Injection (NDA 212121).

March 31, 2023
·
4 min read
Drug Development

AriBio Co., Ltd. to Present Biomarker Data for AR1001 from the Mild to Moderate Alzheimer’s Disease Phase 2 Study at the International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD™ 2023)

AriBio Co., Ltd. announced that David Greeley MD, Chief Medical Officer at AriBio, will present biomarker data from the completed phase 2 study in patients with mild to moderate Alzheimer’s disease who were treated with 10mg and 30mg of AR1001.

March 31, 2023
·
2 min read